Alphamab Oncology files HKEX next-day disclosure return after share repurchase at HKD 8.51

PUBT · 1d ago
Alphamab Oncology files HKEX next-day disclosure return after share repurchase at HKD 8.51
  • Alphamab Oncology repurchased 115,000 ordinary shares on Sept. 1 for treasury, per an HKEX next-day disclosure return.
  • Buyback price range HKD 8.48 to HKD 8.54 per share; aggregate consideration HKD 979,030.
  • No shares were repurchased for cancellation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260901-12314129), on September 01, 2026, and is solely responsible for the information contained therein.